RAWALPINDI: Amid ongoing negotiations with the government, Pakistan Tehreek-e-Insaf (PTI) Chairman Barrister Gohar has said that he met Chief of Army Staff (COAS) General Asim Munir along with ...

The heated exchange occurred during COAS Munir's visit to Peshawar, where he met top provincial political leaders and emphasised: "If there is a state, there is politics. God forbid, without a ...

Pakistan Tehreek-e-Insaf (PTI)'s founding chairman Imran Khan has welcomed the meeting between the party's incumbent Chairman Barrister Gohar Ali Khan and Khyber-Pakhtunkhwa Chief Minister Ali ...

RAWALPINDI (Dunya News) - Lieutenant General S M Kamr-ul-Hassan, Principal Staff Officer (PSO) of the Armed Forces Division of Bangladesh, visited Pakistan and met Chief of Army Staff (COAS) General ...

We are appalled by the recently released Commission on Audit (COA) 2023 report on the Department of Education’s (DepEd) projects worth P1.064 billion down the drain. The implementation of the DepEd ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

ISLAMABAD: Chief of Army Staff (COAS) General Syed Asim Munir emphasised Pakistan’s commitment to fostering amicable ties with Afghanistan while pointing out concerns over the presence of ...

The COAS and the PSO underscored the importance of a stronger defence relationship, emphasizing that the enduring partnership between the two brotherly nations must remain resilient against ...

Says false narrative of a gap between people and the army is mainly driven by a specific agenda from abroad ISLAMABAD: Chief of Army Staff (COAS) General Asim Munir emphasized that Pakistan’s ...

*The names of the hijackers are pseudonyms on condition of speaking to Al Jazeera. Mogadishu, Somalia – Liban Hassan* has spent most of his adult life fishing off Somalia’s northeast coast ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...